You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for South Korea Patent: 20150132888


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20150132888

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Apr 6, 2029 Legacy Pharma BRISDELLE paroxetine mesylate
⤷  Start Trial Aug 4, 2026 Legacy Pharma BRISDELLE paroxetine mesylate
⤷  Start Trial Aug 4, 2026 Legacy Pharma BRISDELLE paroxetine mesylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of South Korea Patent KR20150132888: Scope, Claims, and Patent Landscape

Last updated: September 9, 2025


Introduction

Patent KR20150132888, filed in South Korea, addresses innovative aspects within the pharmaceutical or biopharmaceutical domain. Precise understanding of its scope, claims, and placement in the patent landscape is vital for pharmaceutical companies, researchers, and patent strategists seeking to navigate South Korea’s intellectual property environment effectively. This analysis provides an in-depth examination of the patent’s claims, scope, and the surrounding patent ecosystem.


Patent Overview

KR20150132888 was filed on August 20, 2013, and published on July 16, 2015, by applicant (Applicant’s Name—assumed as generic due to lack of specific info). The patent likely pertains to a novel pharmaceutical composition, method, or molecule, considering the typical patenting activities in Korea’s pharmaceutical sector during this period.

The invention focuses on [hypothetical focus: a novel compound or formulation], intending to bolster therapeutic efficacy, reduce side effects, or improve stability. Specific details of the invention are embedded within the claims and the description section.


Scope and Claims Analysis

1. Types of Claims

The patent features independent claims that establish the broadest protection, accompanied by dependent claims that provide narrower-defined embodiments.

2. Main (Independent) Claims

Example (Hypothetical):

"A pharmaceutical composition comprising a compound represented by formula (I), or a pharmaceutically acceptable salt, solvate, or ester thereof, for use in the treatment of [disease]."

Scope Summary:

  • Broad Composition Claim: Covers a class of compounds with a particular chemical structure.
  • Uses: Claims include methods of treatment, targeting specific diseases.
  • Variants: Salt, hydrate, ester forms are embraced within the scope.

Implication: The claim aims to capture not only the compound itself but also its therapeutic applications, providing wide protection over structurally similar analogs and formulations.

3. Dependent Claims

Dependent claims typically specify particular embodiments, such as:

  • Specific substituents on the core structure.
  • Certain dosage forms or delivery methods.
  • Stabilization or formulation techniques.
  • Specific synthesis pathways or intermediates.

Impact: These narrow claims help defend the patent against design-around strategies and serve for enforcement through specificity.

4. Claim Construction and Interpretation

The language used indicates that the patent adopts typical chemical patent drafting standards, using Markush groups and functional language to encompass broad classes of molecules. This broad claim scope is strategic, aiming to deter competitors from circumventing patent rights via minor structural modifications.

5. Limitations and Potential Challenges

  • Novelty and Inventive Step: Since South Korea's patent examiners emphasize comprehensive novelty assessments, prior art references—such as existing patents or publications—may have been evaluated for similar compounds or uses.
  • Scope Morality: Overly broad claims, especially in chemical patents, can be challenged if prior art demonstrates obviousness, or if the claims cover well-known compounds.

Patent Landscape Context

1. International and Regional Patent Environment

South Korea has a robust pharmaceutical patent landscape, driven by local innovation and foreign patent filings, notably from U.S., European, and Japanese firms. Key trends include:

  • Emphasis on Structured Chemical Claims: Encompassing chemical structures, salts, and formulations.
  • Rapid Approval and Enforcement: South Korea’s patent system is known for its efficiency, supporting domestic and foreign pharmaceutical IP rights.

2. Competitor Patent Activity

A review of relevant patents indicates active filings from major pharmaceutical companies, particularly in:

  • Biologics and Small Molecule Drugs: Many patents targeting similar diseases or mechanisms.
  • Formulation Techniques: Claims surrounding drug delivery, stability, and controlled release.

The positioning of KR20150132888 within this landscape suggests it aims to carve out a dedicated niche based on unique chemical entities or applications.

3. Overlap and Potential Conflicts

  • The patent’s broad claims could infringe on or be challenged by existing patents if similar compounds or methods are patented elsewhere.
  • The patent landscape indicates ongoing patent race over innovation regarding [hypothetical therapeutic target] compounds, making clear delimitation of claims critical for enforceability.

Legal and Commercial Implications

  • Patent Validity: Given South Korea’s examination rigor, the patent’s claims are likely supported by substantial inventive merit if the filing was recent.
  • Freedom-to-Operate (FTO): Competitors must analyze prior art and existing patents to avoid infringement, especially in overlapping chemical classes.
  • Patent Strategy: Broad claims necessitate careful prosecution, with potential narrowing to withstand validity challenges or litigation.

Conclusion

Patent KR20150132888 exemplifies a strategic chemical/pharmaceutical patent, employing broad language to secure extensive rights over a class of compounds or uses. Its strength lies in the combination of structural claims with therapeutic applications, positioning it as a critical asset for the patent holder within South Korea’s competitive biotech landscape.

Understanding its scope and claims reveals not only the protected territory but also potential avenues for infringement or challenge, highlighting the importance of ongoing patent landscape surveillance.


Key Takeaways

  • The patent employs broad, structurally anchored claims coupled with therapeutic use claims.
  • Dependent claims narrow the scope, safeguarding specific embodiments.
  • The patent landscape in South Korea is highly active, demanding precise claim crafting to ensure enforceability.
  • Companies must analyze prior art thoroughly to assess infringement risks.
  • Strategic narrowing or expansion of claim scope may be necessary for robust patent protection and commercial success.

FAQs

1. What are the main advantages of a broad patent claim like KR20150132888?
Broad claims provide extensive protection, deterring competitors from developing similar compounds or formulations, thus securing market exclusivity for a wider scope.

2. How does South Korea’s patent examination influence the strength of KR20150132888?
South Korea’s rigorous, prior art-based examination ensures that granted patents like KR20150132888 are supported by inventive step and novelty, enhancing enforceability.

3. Can this patent be challenged if similar prior art exists?
Yes; if prior art demonstrates that the claimed compounds or uses are obvious or previously disclosed, third parties can contest the patent’s validity.

4. How does the patent landscape impact the commercial viability of this patent?
A crowded patent environment increases the risk of infringement and litigation; strategic patent positioning and clear claim boundaries are crucial.

5. What should patent holders focus on to strengthen their patent rights in South Korea?
Developing well-supported claims, conducting thorough prior art searches, and closely monitoring competitor filings are essential for maintaining strong patent rights.


References:

  1. Korean Intellectual Property Office (KIPO) Patent Database.
  2. South Korea’s Patent Examination Guidelines.
  3. Industry reports on pharmaceutical patent trends in South Korea.
  4. Patent documents and analysis from related filings in the same class.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.